Protocol for Therapeutic Phlebotomy for Elevated Hemoglobin Over 20 g/dL
Indications for Therapeutic Phlebotomy
Therapeutic phlebotomy is indicated for patients with hemoglobin greater than 20 g/dL and hematocrit greater than 65%, associated with headache, increasing fatigue, or other symptoms of hyperviscosity in the absence of dehydration or anemia. 1
Additional indications include:
- Before noncardiac surgery when hematocrit is >65% 1
- Symptomatic hyperviscosity (headache, lethargy, dizziness, poor concentration) 1
Pre-Phlebotomy Assessment
Before initiating therapeutic phlebotomy:
- Confirm hemoglobin >20 g/dL and hematocrit >65%
- Rule out dehydration (which can falsely elevate hemoglobin)
- Check for symptoms of hyperviscosity
- Assess iron status (serum ferritin, transferrin saturation)
- Evaluate hydration status
- Assess baseline vital signs
Phlebotomy Protocol
Volume and Frequency:
Monitoring During Procedure:
- Continuous vital sign monitoring
- Observe for signs of hemodynamic instability
- Monitor for symptoms of hypovolemia
Laboratory Monitoring:
Target Parameters:
- Continue phlebotomy until hemoglobin <20 g/dL and hematocrit <65%
- Aim for resolution of hyperviscosity symptoms
- Avoid iron deficiency (maintain serum ferritin >50 μg/L) 2
Post-Procedure Care
Immediate Care:
- Monitor vital signs for 30-60 minutes post-procedure
- Ensure adequate oral hydration
- Observe for signs of hypovolemia or vasovagal reactions
- Provide written instructions about potential delayed reactions
Hydration:
- Encourage increased fluid intake before and after procedure
- Maintain good hydration between phlebotomy sessions
- Avoid dehydrating activities for 24 hours post-phlebotomy
Activity Restrictions:
- Avoid strenuous physical activity for 24 hours
- Avoid hot environments (saunas, hot tubs) on day of procedure
- No alcohol consumption for 24 hours post-procedure
Follow-Up Guidelines
Short-term Follow-up:
- Reassess symptoms within 1-2 weeks after initial phlebotomy
- Check hemoglobin and hematocrit levels before next session
- Evaluate need for continued phlebotomy based on clinical response and laboratory values
Long-term Monitoring:
- Once target hemoglobin/hematocrit achieved, establish maintenance schedule
- Monitor hemoglobin/hematocrit every 3-6 months
- Check serum ferritin and transferrin saturation every 6 months 2
- Adjust frequency based on rate of hemoglobin/hematocrit rise
Warning Signs Requiring Immediate Attention:
- Instruct patients to seek medical attention for:
- Unusual bleeding or bruising
- Severe headache or dizziness
- Extreme fatigue
- Symptoms of iron deficiency (glossitis, angular cheilitis)
- Instruct patients to seek medical attention for:
Important Cautions
Avoid Repeated Routine Phlebotomies:
- Repeated routine phlebotomies are not recommended due to risk of iron depletion, decreased oxygen-carrying capacity, and stroke 1
Iron Monitoring:
Special Considerations:
Contraindications:
- Anemia
- Hypovolemia
- Hemodynamic instability
- Active infection
By following this protocol, therapeutic phlebotomy can effectively manage hyperviscosity symptoms in patients with elevated hemoglobin while minimizing risks of complications such as iron deficiency and stroke.